These fifteen DEGs, including AKT2, CCL2, HSP90AA1, PDE5A, PTGS1, BCHE, SERPINB5, CA2, SRC, DGKA, HIF1A, PTGS2, ABCA1, DPYD, and AKR1C3 were potential target of wogonin to enhance gemcitabine sensitivity in pancreatic cancer. This evidence concerns the gene BCHE and pancreatic neoplasm.